gastric disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age >=18 years, both sexes, American Society of Anesthesiologists (ASA) classification between I-II, body mass index (BMI) of 18-25kg/m2, no history of analgesic drug abuse, no history of severe cardiopulmonary disease, no history of asthma, no use of sedative drugs within 24 hours before examination
Exclusion criteria
Exclusion criteria: Pregnant and lactating women; Patients with obvious difficult airway and esophageal cancer; Patients with vital organ dysfunction; Accompanied by cognitive impairment or mental disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body movement, cough occurrence; | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic blood pressure and diastolic blood pressure before induction, immediately after the completion of butorphanol injection, immediately after the completion of propofol injection, immediately after the end of gastroscopy, and at awakening;Heart rate before induction, immediately after the completion of butorphanol injection, immediately after the completion of propofol injection, immediately after the end of gastroscopy, and upon awakening;endoscopy time;dosage of propofol;recovery time;Blood oxygen saturation before induction, immediately after butorphanol injection, immediately after propofol injection, immediately after gastroscopy, and on recovery;Postoperative score of 10minVAS; | — |
Countries
China
Contacts
Binzhou Medical University Hospital